Have hep C? Treatment and re-treatment now available!
Hep C TIP News | Hepatitis C Treatment Information Project
by Deb Schmitz
3y ago
Anyone feeling freer these days? Could it be from the fact that even if your liver is healthy you can now access hep C treatment through PharmaCare in BC. Yay!!! That’s not all!!  The first pan-genotypic treatment (treats all hep C genotypes)  – VOSEVI – is now approved and listed with BC PharmaCare.   VOSEVI treats people with or without cirrhosis and those who have tried treatment in past and either couldn’t complete due to side effects or who didn’t get cured. Here’s the BC Government official announcement from last week.  And, we’ve update the hep C treatment page ..read more
Visit website
2017 Liver Meeting Highlights
Hep C TIP News | Hepatitis C Treatment Information Project
by Deb Schmitz
3y ago
Attending the Liver Meeting 2017, the American Association for the Study of Liver Diseases (AASLD)‘s 68th annual meeting, this year were not only researchers and physicians, but also a number of different blog writers. The below are links to some abstracts and blog posts about information presented at this year’s Liver Meeting. A Few 2017 Liver Meeting Highlights A Sampling of Blog Posts by Clinical Care Options GECCO: Sofosbuvir/Velpatasvir With or Without RBV Demonstrates High Efficacy in Genotype 3 HCV–Infected Patients, Including Cirrhotics in Real-World Setting SWIFT-C: 8-Week Ledipas ..read more
Visit website
Gilead Receives Health Canada Approval for VOSEVI™, the First Once-Daily, Single Tablet HCV Regimen for Re-Treatment
Hep C TIP News | Hepatitis C Treatment Information Project
by Deb Schmitz
3y ago
Please note:  VOSEVI is available to eligible patients in Canada but is not yet covered by BC PharmaCare (or any provincial plans).  VOSEVI is included in Gilead’s Momentum Patient Support Program (information, including contact information, is available below and here). See the Hep C Treatment Diagram on the left hand side of this page (homepage has 2 versions) for a picture of Canada’s drug approval system and where hep C treatments are at in it.  VOSEVI is at Step 3 and will be progressing through the approval process.  That takes time.  VOSEVI will be added to the ..read more
Visit website
AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes
Hep C TIP News | Hepatitis C Treatment Information Project
by Deb Schmitz
3y ago
Please note:  MAVIRET is available to eligible patients in Canada but is not yet covered by BC PharmaCare (or any provincial plans).  MAVIRET is included in AbbVie’s patient support program, AbbVie Care. Information, including contact information, is available here and here. See the Hep C Treatment Diagram on the left hand side of this page (homepage has 2 versions) for a picture of Canada’s drug approval system and where hep C treatments are at in it.  MAVIRET is at Step 3 and will be progressing through the approval process.  That takes time.  MAVIRET (glecaprevir/pi ..read more
Visit website
National screening guidelines for hep C abandon baby boomers.
Hep C TIP News | Hepatitis C Treatment Information Project
by Deb Schmitz
3y ago
Once again, the largest group of people at risk for living with hepatitis C in Canada  – baby boomers – are excluded from the Canadian Task Force on Preventive Health (CTFPH)’s hepatitis C screening guideline recommendations. As a community-based, lived experience organization, we urge testing of all at-risk groups, including those born between 1945 – 1965 in BC. Two-thirds – some 55,000 people call in that group in here in BC. We also urge the new British Columbia Minister of Health, when that person is appointed, to consider the extensive data in British Columbia that supports identifyi ..read more
Visit website
Candidate Questionnaire – 2017 Provincial Election
Hep C TIP News | Hepatitis C Treatment Information Project
by Deb Schmitz
3y ago
All candidates running for office in this 2017 provincial election have been sent this questionnaire and background information.  Results from candidates and parties will be posted in blogs leading up to the election.   Our question:  Do you support PHCN’s 5 Point Plan to help eliminate hepatitis C from BC by 2030? Feel free to check in with your candidates in your riding about our question.  Find your candidates here:  http://elections.bc.ca/2017-general-election/candidates/ Feel free to email us at BCElection2017@pacifichepc.org Pacific Hep C Network BC Electio ..read more
Visit website
Hepatitis C Elimination is Possible and Essential
Hep C TIP News | Hepatitis C Treatment Information Project
by Hep C TIP
3y ago
Twelve years ago a neonatal nurse adopted Kagen, a blonde haired blue-eyed baby boy. He’s now tall, sports a buzz cut, and likes playing Pokemon Go and visiting Build-A-Bear. With the desire to help people in rural Appalachia, Naomi became a registered nurse and had dreams of one day becoming a doctor. While working in the fast paced ICUs in Nashville, Naomi remembers often being stuck by needles and being covered in bodily fluids while helping patients. As a boy, Abdel remembers lining up once a month with his classmates for injections against schistosomiasis, a parasitic disease spread by wa ..read more
Visit website
Relapse, Recurrence, Null & Partial Response/rs: The Basics
Hep C TIP News | Hepatitis C Treatment Information Project
by Hep C TIP
3y ago
In hepatitis C and hep C treatment there are three ‘R’s that are big, sad, and scary. They are the bringers of sadness that if doctors, friends, and communities could protect someone from, they would. The Three ‘R’s of Hepatitis C Treatment Recurrence When treatment has been successful but over time the person has been infected with the hepatitis C virus again. Relapse When treatment has been successful but over time the virus has come back. Null/Non Response/rs & Partial Response/rs A null response is when treatment doesn’t work to suppress the virus. The viral count of hep C in one’s blo ..read more
Visit website
Technivie and BC PharmaCare
Hep C TIP News | Hepatitis C Treatment Information Project
by Hep C TIP
3y ago
Technivie, the hepatitis C treatment, was approved for use in Canada in October 2015 and then later went on to pursue approval for BC PharmaCare coverage in January 2016. However, negotiations that may have led to BC PharmaCare coverage being granted in the near future were closed as an agreement couldn’t be reached between AbbVie and pCPA at this time. Technivie is still an approved hepatitis C genotype 4 treatment in Canada. For more information about this, please contact the AbbVie Care program at: 1-844-471-2273. Technivie (Ombitasvir / Paritaprevir / Ritonavir) Technivie Background ..read more
Visit website
Holkira Pak and BC PharmaCare
Hep C TIP News | Hepatitis C Treatment Information Project
by Hep C TIP
3y ago
The hepatitis C treatment Holkira Pak was approved for use in Canada in March 2015 and then was later approved for BC PharmaCare coverage in July  2015. Although Holkira Pak is still approved for use in Canada and has an amazingly high cure rate, as of March 23, 2017, BC PharmaCare has decided not to approve new requests for coverage. For patients whose coverage was approved before March 23, 2017, BC PharmaCare will continue coverage until their current Special Authority expires. For more information about this change, please contact your doctor, nurse, or call the AbbVie Care program at ..read more
Visit website

Follow Hep C TIP News | Hepatitis C Treatment Information Project on FeedSpot

Continue with Google
Continue with Apple
OR